S.Res. 560Senate109th Congress (2005-2007)Passed Congress

A resolution supporting efforts to increase childhood cancer awareness, treatment, and research.

Introduced September 7, 2006

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateFloor Latest Action

Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S9212; text as passed Senate: CR S9212; text of measure as introduced: CR S9193)

September 7, 2006

View full timeline
SenateIntro Referral

Introduced in Senate

September 7, 2006

SenateFloor

Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S9212; text as passed Senate: CR S9212; text of measure as introduced: CR S9193)

September 7, 2006

Floor Debate

1 member

What members said about S.Res. 560 on the floor

1 Republican
William H. Frist
Sen. William H. FristR-TN · Sep 7, 2006

Mr. President, I ask unanimous consent that the Senate proceed to the consideration of S. Res. 560 which was submitted earlier today. Mr. President, I ask unanimous consent that the resolution be…

Bill Text

Latest available legislative text

Reading Mode
Latest
Agreed to SenateIssued September 7, 2006

III

109th CONGRESS

2d Session

S. RES. 560

IN THE SENATE OF THE UNITED STATES

September 7 (legislative day, September 6), 2006

Mr. Coleman (for himself, Mr. Allen, Mr. Bayh, Mr. Brownback, Mr. Carper, Mr. Chafee, Mr. Cochran, Ms. Collins, Mr. Cornyn, Mrs. Feinstein, Mr. Graham, Mr. Hatch, Mr. Isakson, Mr. Johnson, Mr. Kerry, Mr. Lieberman, Mrs. Lincoln, Mr. Menendez, Ms. Mikulski, Ms. Murkowski, Mrs. Murray, Mr. Reed, Mr. Salazar, Mr. Santorum, Mr. Sarbanes, Mr. Schumer, Ms. Stabenow, Mr. Talent, and Mr. Voinovich) submitted the following resolution; which was considered and agreed to

RESOLUTION

Supporting efforts to increase childhood cancer awareness, treatment, and research.

Whereas an estimated 12,400 children will be diagnosed with cancer in the year 2005;

Whereas cancer is the leading cause of death by disease in children under age 15;

Whereas an estimated 2,300 children will die from cancer in the year 2005;

Whereas the incidence of cancer among children in the United States is rising by about one percent each year;

Whereas 1 in every 330 Americans develops cancer before age 20;

Whereas approximately 8 percent of deaths of those between 1 and 19 years of age are caused by cancer;

Whereas while some progress has been made, a number of funding opportunities for childhood cancer research still remain;

Whereas increasing the focus on childhood cancer research requires the recruitment of additional investigators and physicians to pediatric oncology;

Whereas peer-reviewed clinical trials are the standard of care for pediatrics and have improved cancer survival rates among children;

Whereas the number of survivors of childhood cancer continues to grow, with about 1 in 640 adults between the ages of 20 and 39 having a history of cancer;

Whereas up to 2/3 of childhood cancer survivors are likely to experience at least one late effect from treatment, many of which may be life-threatening;

Whereas some late effects of cancer treatment are identified early in follow-up and are easily resolved, while others may become chronic problems in adulthood and may have serious consequences; and

Whereas 89 percent of children with cancer experience substantial suffering in the last month of life: Now, therefore, be it

That it is the sense of the Senate that Congress should support—

(1)

public and private sector efforts to promote awareness about the incidence of cancer among children, the signs and symptoms of cancer in children, treatment options, and long-term follow-up;

(2)

public and private investment in childhood cancer research to improve prevention, diagnosis, treatment, rehabilitation, post-treatment monitoring, and long-term survival;

(3)

medical trainees and investigators in the field of pediatric oncology;

(4)

policies that provide incentives to encourage the development of drugs and biologics designed to treat pediatric cancers;

(5)

policies that encourage participation in clinical trials;

(6)

medical education curricula designed to improve pain management for cancer patients; and

(7)

policies that enhance education, services, and other resources related to late effects from treatment.